To support the development of the next generation of immunotherapy experts, this two -year award (24 months) aims to provide support for cancer immunotherapy by an individual who has an MD, PhD or combined MD/PhD degree and a vested interest in furthering the research and translation of cancer immunotherapy. The application period is now closed.
Click here for full details and application requirements.Click here for frequently asked questions.
Made possible by an educational grant from Bristol Myers Squibb.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com